Stocks News

LAST PRICE
23.0700
TODAY'S CHANGE (%)
Trending Down-0.4300 (-1.8298%)

Bid / Lots
21.9800/ 1
Ask / Lots
23.7800/ 1
Open / Previous Close
23.5600 / 23.5000
Day Range
Low 22.6000
High 23.5600
52 Week Range
Low 15.3100
High 26.8400
Volume
1,292,208
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 13, 2024
- Xencor Insider Sold Shares Worth $1,612,639, According to a Recent SEC Filing, from 5:59PM ET on Wednesday Nov 13, 2024 by MT Newswires
  5:59PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: XNCR
  05:59 PM EST, 11/13/2024 (MT Newswires) -- John R Desjarlais, Senior Vice President, CSO, on November 11, 2024, sold 68,684 shares in Xencor (XNCR) for $1,612,639. Following the Form 4 filing with the SEC, Desjarlais has control over a total of 200,...
Nov 8, 2024
- DJ Xencor Price Target Raised to $34.00/Share From $32.00 by BMO Capital, from 10:54AM ET on Friday Nov 08, 2024 by Dow Jones
  10:54AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: XNCR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/XNCR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 10:54 ET (15:54 GMT)
Nov 7, 2024
- DJ Xencor Is Maintained at Overweight by JP Morgan, from 1:06PM ET on Thursday Nov 07, 2024 by Dow Jones
  1:06PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: XNCR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/XNCR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 13:06 ET (18:06 GMT)
Nov 6, 2024
- -- Earnings Flash (XNCR) XENCOR Posts Q3 Revenue $10.7M, from 4:02PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:02PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: XNCR
  04:02 PM EST, 11/06/2024 (MT Newswires) -- ...
- -- Earnings Flash (XNCR) XENCOR Posts Q3 Loss $-0.71, from 4:01PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:01PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: XNCR
  04:01 PM EST, 11/06/2024 (MT Newswires) -- ...

Yesterday
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX, from 20 hours ago by Dow Jones
  20 hours ago by Dow Jones
  Companies Mentioned: TVTX
Nov 15, 2024
- DJ Dynavax Technologies Down Over 7%, On Track for Largest Percent Decrease Since August 2022 -- Data Talk, from 1:51PM ET on Friday Nov 15, 2024 by Dow Jones
  1:51PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: DVAX
Nov 14, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX, from 6:46PM ET on Thursday Nov 14, 2024 by Dow Jones
  6:46PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: TVTX
- --Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7, from 12:56PM ET on Thursday Nov 14, 2024 by MT Newswires
  12:56PM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: MNKD
- DJ Travere Therapeutics Is Maintained at Neutral by Piper Sandler, from 9:28AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:28AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: TVTX
Nov 13, 2024
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: TVTX
- Travere Therapeutics Completes $143.8 Million Public Offering, from 6:28AM ET on Wednesday Nov 13, 2024 by MT Newswires
  6:28AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: TVTX
Nov 12, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX, from 6:02PM ET on Tuesday Nov 12, 2024 by Dow Jones
  6:02PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TVTX
- Arcus Biosciences Announces New Employment Inducement Grants, from 4:35PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:35PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: RCUS
- Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TVTX

Xencor Inc
NASDAQ:XNCRUnited States

Search Criteria

Nov 13, 2024

Xencor Insider Sold Shares Worth $1,612,639, According to a Recent SEC Filing, from 5:59PM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 8, 2024

DJ Xencor Price Target Raised to $34.00/Share From $32.00 by BMO Capital, from 10:54AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

DJ Xencor Is Maintained at Overweight by JP Morgan, from 1:06PM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

-- Earnings Flash (XNCR) XENCOR Posts Q3 Revenue $10.7M, from 4:02PM ET on Wednesday Nov 06, 2024 by MT Newswires

-- Earnings Flash (XNCR) XENCOR Posts Q3 Loss $-0.71, from 4:01PM ET on Wednesday Nov 06, 2024 by MT Newswires

Peers Headlines

Yesterday

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX, from 20 hours ago by Dow Jones

Nov 15, 2024

DJ Dynavax Technologies Down Over 7%, On Track for Largest Percent Decrease Since August 2022 -- Data Talk, from 1:51PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX, from 6:46PM ET on Thursday Nov 14, 2024 by Dow Jones

--Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7, from 12:56PM ET on Thursday Nov 14, 2024 by MT Newswires

DJ Travere Therapeutics Is Maintained at Neutral by Piper Sandler, from 9:28AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:00PM ET on Wednesday Nov 13, 2024 by Dow Jones

Travere Therapeutics Completes $143.8 Million Public Offering, from 6:28AM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 12, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX, from 6:02PM ET on Tuesday Nov 12, 2024 by Dow Jones

Arcus Biosciences Announces New Employment Inducement Grants, from 4:35PM ET on Tuesday Nov 12, 2024 by Dow Jones

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones